IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies. The introduction of IPTonline in 2003 has allowed the magazine to extend its reach and offer a high-quality archive of articles and company innovation features, plus industry news and events. With the arrival of the Samedan App in 2013 and the switch to a digital-only publication in December 2014, the magazine's technology-driven focus has become stronger than ever. As the supporter of many leading tradeshows and exhibitions, IPT is ideally placed to serve the needs of its readers and advertisers.
A biotechnology entrepreneur and immunologist by training with over two decades of experience in anti-infectives research & development, Deborah studied at University College London and then worked in postdoctoral positions in internationally acclaimed laboratories in San Diego and Ghent before moving to Aberdeen where she founded NovaBiotics in 2004. The business has since become a leading global biotechnology business developing a portfolio of first-in-class anti-infective therapies addressing the urgent, unmet need for safe and effective antibacterial and antifungal therapies. Deborah was recently named as one of the 20 leading females in European biotechnology. She is editor of the European Biopharmaceutical Review and Innovations in Pharmaceutical Technology, a member of the Board of the Scottish Life Sciences Association and Opportunity North East (ONE) (Life Sciences), she chairs the Medicines Discovery Catapult-Cystic Fibrosis Trust Syndicate and sits on the BioIndustry Associations’ working group on Antimicrobial Resistance. Deborah is a proud Trustee of the charity Crohns’ in Childhood Research Association.
Samedan Ltd, one of Europe's leading pharmaceutical magazine publishers, produce a range of high-quality pharmaceutical trade titles, which are well-respected within the industries they represent. Samedan Ltd offers five established titles: European Pharmaceutical Contractor, Pharmaceutical Manufacturing and Packing Sourcer, European Biopharmaceutical Review, International Clinical Trials and Innovations in Pharmaceutical Technology.
These five magazines attract high-profile authors that cover the industry's hottest topics and the latest cutting-edge developments. Each with their own specific audience, these quarterly 'must-have' publications epitomise the art of capturing a niche market. Samedan Ltd is constantly striving to extend its impeccable reputation, with quality and insight at the forefront. Visit: www.samedanltd.com